Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Sigrid Therapeutics AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 Equal arrow 0
Earnings before taxes -30,607 More Arrow -21,882 More Arrow -20,739
EBITDA -30,932 More Arrow -21,520 More Arrow -20,316
Total assets 73,432 Less Arrow 55,012 More Arrow 64,876
Current assets 66,770 Less Arrow 51,769 More Arrow 62,369
Current liabilities 9,684 Less Arrow 4,588 Less Arrow 3,649
Equity capital 63,748 Less Arrow 50,424 More Arrow 61,227
- share capital 726 Less Arrow 655 Less Arrow 643
Employees (average) 7 More Arrow 9 Less Arrow 7

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 86.8% More Arrow 91.7% More Arrow 94.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -41.7% More Arrow -39.8% More Arrow -32.0%
Current ratio 689.5% More Arrow 1128.4% More Arrow 1709.2%
Return on equity (ROE) -48.0% More Arrow -43.4% More Arrow -33.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -2 More Arrow 2 Equal arrow 2
Chg. No. of employees % -22% More Arrow 29% More Arrow 40%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.